Navigation Links
Cone-Beam CT faster, potentially more accurate than conventional mammography
Date:12/27/2007

Cone-beam breast CT provides exceptional tissue contrast and can potentially reduce examination time with comparable radiation dose to conventional 2D mammography, according to a new study by a team of researchers from the University of Texas M. D. Anderson Cancer Center in Houston.

Cone-beam breast CT employs a large area x-ray beam in conjunction with a flat panel x-ray detector to scan and generate 3D images of the breast. The scanner is placed below a table on which the patient lies prone with the breast protruding through an opening. Only the breast is exposed to radiation resulting in improved image quality and sparing the rest of the patients body from unnecessary radiation exposure. The scan can be completed in less than one minute with a single complete rotation of the x-ray tube-detector gantry around the breast. Unlike conventional CT, the patient is not moved through the gantry during scanning.

For the study, the researchers used cone-beam CT on 12 mastectomy specimens. The researchers discovered that structured noise on cone-beam CT was minimal because of the absence of overlapping tissue; that breast anatomy was well resolved on all images as skin, adipose, and glandular regions; and that microcalcifications within cancers were clearly shown. In addition, they discovered that the detection of cancers based on morphologic assessment of tissue structures could potentially be improved compared with mammography because of the lack of overlapping glandular tissue.

Conventional 2D mammography is currently the most prevalent imaging technique for screening and diagnosis of breast cancers. However, the 2D projection images can overlap normal tissue, soft tissue masses, and calcifications and affect the detection and visualization of cancer. Despite the advantage of excellent spatial resolution, conventional mammography is unable to diagnose all cancers, especially early cancers in dense breasts, and cancers in high risk w
'/>"/>

Contact: Necoya Tyson
necoya@arrs.org
703-858-4304
American Roentgen Ray Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Regulatory Affairs Associates Gets New Drugs Tested Faster, Wins 2007 Innovation Michigan Award
2. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
3. Common abdominal pain may be due to a potentially treatable newly recognized inflammatory reaction
4. Molecular profiling can accurately predict survival in colon cancer patients
5. PET scans can accurately detect a breast tumors response to chemotherapy
6. ADA Calls for Scientifically Accurate Patient Brochure Explaining Filling Choices
7. Dr. Laura Jana Offers Parents Five Key Ways to Ensure Accurate Dosing of Liquid Medication to Infants
8. CT angiography highly accurate, multicenter trials show
9. CT Angiography Highly Accurate: Multicenter Trials Show
10. Breaking Studies at AARC Congress Show Masimo SET and Masimo Rainbow SET to be Accurate, Effective and Uniquely Beneficial in Detecting and Tracking Disease States
11. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...Mass., Nov. 21 Cardiosolutions, In...unced the appointment of Dr. Lars,Svensson, M.D.,...Dr. Svensson,is currently the Director of the Cen... Syndrome and Connective Tissue Disorder Clinic in...rgery at Cleveland Clinic. , Cardiosolution...
(Date:11/21/2008)... New data presented at the 61st Annu...y of America showed JANUVIA™ (sitagliptin), ...gnificantly reduced blood sugar levels in elderly ...ed with hypoglycemia (low blood sugar). In this st...e no reports of hypoglycemia in either the JANUVIA...
(Date:11/21/2008)..., Nov. 21 Unilens Vision...hange: UVI), which develops, licenses,manufactur...es, today reported,its operating results for the ..., Net sales, excluding royalty income, incre...compared with $1,673,361 in the previous year firs...
(Date:11/21/2008)...v. 21 Attorneys representing consu...posed landmark $350 million settlement,with healt...ttle allegations the,company fraudulently inflate...,manipulating drug-pricing benchmarks. , (...7/AQM144LOGO ) , The lawsuit, filed under t...
Breaking Medicine News(10 mins):Health News:Cardiosolutions Names Dr. Lars Svensson Chief Surgical Officer 2Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 2Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 3Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 4Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 5Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 6Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 7Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 8Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 9Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 10Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 11Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 12Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 13Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 14Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 15Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 16Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 17Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 18Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 19Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 20Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 21Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 22Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 23Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 24Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 25Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 26Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 27Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 28Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 29Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 30Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 31Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 32Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 33Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 34Health News: New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 35
...ification of a new biochemical switch that affects...d with learning could pave way for better understa... A protein named “ Reelin”, an important componen... focus of the research. During development, reelin...
... cells are truly a marvel. Yes! It has been proven...have used fetal skin cells to successfully heal yo... revolutionary procedure avoids the need to remove...he skin cells that are taken from an aborted fetus...
...isk of developing inflammatory disorders like rheu...ghtly-coloured fruits and vegetables like oranges,...nt beta-cryptoxanthin, both of which are found in ...g, may act as antioxidants, and protect the body a...
...he first time, a gene linked to the disease tuberc...ol the onset of the disease. The gene NRAMP1 is kn...ike leprosy // and rheumatoid arthritis. Different...he speed at which tuberculosis develops. Certain f...
Other Medicine News:Health News:Learning process to be regulated by altering brain protein 2
(Date:11/18/2008)...wire/ -- Arlington Medical Resources (AMR), a,pro...aceutical and diagnostic,imaging industries, find...was,sold in the U.S. during the third quarter of ... immune globulin (IVIG) and was launched in the fi...om the blood plasma of thousands,of donors and is...
(Date:11/18/2008)...008 Faces of Influenza survey underscores that mot...nza; Mother and Gold Medalist Kristi Yamaguchi joi...ewswire/ -- While 78 percent of mothers in the Uni...ally life-threatening disease that can strike anyo... get vaccinated this season, according to a new su...
(Date:11/13/2008)...PRNewswire-FirstCall/ -- Hologic, Inc.,(Nasdaq: H...ier of premium,diagnostics, medical imaging system...ealthcare needs of women, today announced the resu... trial. The Cervista HPV high-risk,test is current...cted to be,launched in the European Union (EU) ear...
(Date:11/13/2008)...inds Statins Cut Risk of Heart Attacks, Deaths, R...diovascular Disease,is the leading cause of death ...dreds of millions of dollars and causing untold su... fatal disease - even among those who,weren,t thou...llions of people could cut their risk of a,heart a...
Breaking Medicine Technology:Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 3Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 4Seniors Can Be Heartened by New Study on Statins 2Concuity Announces the Availability of PriceAdvisor 22615 1Concuity Announces the Availability of PriceAdvisor 22615 2Concuity Announces the Availability of PriceAdvisor 22615 3Concuity Announces the Availability of PriceAdvisor 22615 4Night Hospitalist Company LLC Launches First Nighttime Hospitalist Telemedicine Solution 22612 1Night Hospitalist Company LLC Launches First Nighttime Hospitalist Telemedicine Solution 22612 2HealthPartners Medical Group in Michigan City purchases IDC digital radiography system 22609 1HealthPartners Medical Group in Michigan City purchases IDC digital radiography system 22609 2HealthPartners Medical Group in Michigan City purchases IDC digital radiography system 22609 3Keryx Biopharmaceuticals to Present at the Jefferies 26 Co Healthcare Conference 6180 1Keryx Biopharmaceuticals to Present at the Jefferies 26 Co Healthcare Conference 6180 2
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
Medicine Products: